Geode Capital Management’s BeOne Medicines Ltd. American Depositary Shares ONC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$8.62M Sell
35,616
-1,385
-4% -$335K ﹤0.01% 2453
2025
Q1
$10.1M Sell
37,001
-1,251
-3% -$340K ﹤0.01% 2292
2024
Q4
$7.07M Buy
38,252
+488
+1% +$90.1K ﹤0.01% 2562
2024
Q3
$8.48M Sell
37,764
-50
-0.1% -$11.2K ﹤0.01% 2472
2024
Q2
$5.39M Buy
37,814
+1,739
+5% +$248K ﹤0.01% 2683
2024
Q1
$5.64M Buy
36,075
+350
+1% +$54.7K ﹤0.01% 2633
2023
Q4
$6.44M Sell
35,725
-90
-0.3% -$16.2K ﹤0.01% 2574
2023
Q3
$6.44M Buy
35,815
+202
+0.6% +$36.3K ﹤0.01% 2509
2023
Q2
$6.35M Sell
35,613
-9,295
-21% -$1.66M ﹤0.01% 2565
2023
Q1
$9.68M Sell
44,908
-201,460
-82% -$43.4M ﹤0.01% 2273
2022
Q4
$54.2M Sell
246,368
-6,918
-3% -$1.52M 0.01% 1093
2022
Q3
$34.1M Buy
253,286
+16,759
+7% +$2.25M 0.01% 1364
2022
Q2
$38.1M Buy
236,527
+3,252
+1% +$524K 0.01% 1305
2022
Q1
$43.7M Buy
233,275
+8,252
+4% +$1.55M 0.01% 1345
2021
Q4
$60.6M Buy
225,023
+18,307
+9% +$4.93M 0.01% 1162
2021
Q3
$74.5M Buy
206,716
+9,899
+5% +$3.57M 0.01% 980
2021
Q2
$67.1M Buy
196,817
+12,171
+7% +$4.15M 0.01% 1061
2021
Q1
$63.8M Buy
184,646
+9,227
+5% +$3.19M 0.01% 1036
2020
Q4
$45M Sell
175,419
-33,384
-16% -$8.57M 0.01% 1171
2020
Q3
$58.7M Buy
208,803
+12,230
+6% +$3.44M 0.01% 831
2020
Q2
$36.5M Buy
196,573
+5,033
+3% +$935K 0.01% 1077
2020
Q1
$23.3M Buy
191,540
+18,168
+10% +$2.21M 0.01% 1201
2019
Q4
$28.3M Buy
173,372
+6,902
+4% +$1.13M 0.01% 1332
2019
Q3
$20.2M Buy
166,470
+7,890
+5% +$956K ﹤0.01% 1485
2019
Q2
$19.5M Buy
158,580
+19,700
+14% +$2.42M ﹤0.01% 1501
2019
Q1
$18.2M Buy
138,880
+4,823
+4% +$630K ﹤0.01% 1476
2018
Q4
$18.6M Buy
134,057
+108,218
+419% +$15M 0.01% 1330
2018
Q3
$4.45M Buy
25,839
+998
+4% +$172K ﹤0.01% 2422
2018
Q2
$3.82M Buy
24,841
+7,206
+41% +$1.11M ﹤0.01% 2489
2018
Q1
$2.96M Buy
17,635
+245
+1% +$41.2K ﹤0.01% 2544
2017
Q4
$1.7M Buy
17,390
+2,706
+18% +$264K ﹤0.01% 2848
2017
Q3
$1.52M Buy
14,684
+973
+7% +$101K ﹤0.01% 2903
2017
Q2
$616K Buy
13,711
+4,283
+45% +$192K ﹤0.01% 3282
2017
Q1
$345K Buy
+9,428
New +$345K ﹤0.01% 3461